These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6202686)

  • 1. Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma.
    Gitel SN; Medina VM; Wessler S
    J Biol Chem; 1984 Jun; 259(11):6890-5. PubMed ID: 6202686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human factor Xa by various plasma protease inhibitors.
    Ellis V; Scully M; MacGregor I; Kakkar V
    Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA; Schapira M; Colman RW
    J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
    Fuchs HE; Shifman MA; Pizzo SV
    Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.
    Fuchs HE; Pizzo SV
    J Clin Invest; 1983 Dec; 72(6):2041-9. PubMed ID: 6196377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex-formation and inhibition of urokinase by blood plasma proteins.
    Waller EK; Schleuning WD; Reich E
    Biochem J; 1983 Oct; 215(1):123-31. PubMed ID: 6194790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat factors X and Xa: demonstration of factor Xa in rat plasma.
    Enjyoji K; Miyazaki K; Kato H
    J Biochem; 1991 Jun; 109(6):890-8. PubMed ID: 1718949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
    Ellis V; Scully MF; Kakkar VV
    Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
    Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
    J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III.
    Fuchs HE; Michalopoulos GK; Pizzo SV
    J Cell Biochem; 1984; 25(4):231-43. PubMed ID: 6334690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
    de Agostini A; Lijnen HR; Pixley RA; Colman RW; Schapira M
    J Clin Invest; 1984 Jun; 73(6):1542-9. PubMed ID: 6725552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of divalent metal cations on the inhibition of human coagulation factor Xa by plasma proteinase inhibitors.
    Ellis V; Scully M; Kakkar V
    Biochim Biophys Acta; 1983 Sep; 747(1-2):123-9. PubMed ID: 6192845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of inhibition of platelet coagulant activity.
    Ellis V; Scully MF; Kakkar VV
    Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of inflammatory proteinase, medullasin, by alpha 2-macroglobulin and ovomacroglobulin.
    Ikai A; Nakashima M; Aoki Y
    Biochem Biophys Res Commun; 1989 Feb; 158(3):831-6. PubMed ID: 2465765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
    Hall P; Tryon E; Nikolai TF; Roberts RC
    Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the kinetics of inhibition of activated coagulation factor X in human plasma: the effect of plasma and inhibitor concentration.
    Jesty J
    Anal Biochem; 1986 Feb; 152(2):402-11. PubMed ID: 2421604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.